Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 10, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for December 10, 2007 Subscribe to this News Feed    
 

Medical Treatments Toxic to the Heart

Breakthrough in CoQ10 Nutrient; Prevents Cell Damage to Improve Heart Health. High cholesterol, diabetes, and cancer all have one thing in common: their medical treatments often rob the body of the very nutrient it needs to maintain heart and brain health, Coenzyme Q10.

East Hanover, NJ (PRWEB) December 10, 2007 -- High cholesterol, diabetes, and cancer all have one thing in common: their medical treatments often rob the body of the very nutrient it needs to maintain heart and brain health, Coenzyme Q10. In the fifty years since its discovery, CoQ10 has been clinically shown to play a vital role in the mitochondria, the body's cell production powerhouse, but it is QuTen Research Institute's recent technological breakthrough that has allowed the large molecular weight of CoQ10 to be formulated in a daily dietary supplement, Qunol Ultra CoQ10, that may actually help prevent cell damage and improve health in just weeks.

Dr. Frederic J. Vagnini, Heart Surgeon
Dr. Frederic J. Vagnini, Heart Surgeon

Dr. Frederic Vagnini, board certified heart surgeon and host of New York City radio program, "The Heart Show," explained Qunol's breakthrough Ultra CoQ10 supplement, "In the past, absorbing CoQ10 supplements in the body was difficult because its molecule dissolved only in fats. Qunol Ultra CoQ10 supplement is both water and fat soluble and has demonstrated 300% better absorption than other CoQ10 supplements." Qunol's CoQ10 absorption, the Dr. pointed out, results in increased heart energy and a more potent anti-oxidant effect in just weeks - not the months that fat-soluble supplements delivered.

Because the body's ability to produce the Coenzyme Q10 nutrient decreases steadily with age, 50% by the age of 43, cells become damaged and degenerative diseases occur. Worse, many of the medications used to treat degenerative diseases deplete the cellular energy the body needs to function fully. "For example," shared the heart surgeon, "CoQ10 shares the same synthetic pathway in the body as cholesterol. When you block cholesterol with statins, you block the body's natural production of CoQ10," adding, "If you take statins, its important to take a CoQ10 supplement to maintain blood pressure and a strong and healthy heart."

Before using a dietary supplement, consult your physician. For more information on Qunol Ultra CoQ10, visit www.qunol.com.

References
1. Bhagavan HN, Chopra RJ. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research, 2006; 40(5):445-453.
2. Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. Coenzyme Q10 in health and disease. Eur J of Clin Nutr 1999; 53:764-770.
3. Langsjoen PH, Langsjoen AM. Overview of the use of coenzyme Q10 in cardiovascular disease. Biofactors 1999;9:273-284.
4. Greensberg S, Frishman WH. Co-enzyme Q10: A new drug for cardiovascular disease. J Clin Pharmacol 1990;30:596-608.
5. Gold DR, Cohen BH. Treatment of mitochondrial cytopathies. Semin Neurol 2001; 21:309-325.
6. Schon EA, DiMauro S. Medicinal and genetic approaches to the treatment of mitochondrial disease. Curr Med Chem 2003;10:2523-2533.
7. Conklin KA. Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther 2005;4:110-130.
8. Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of coenzyme Q10 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): A critical review. Adv Therap 1998;15:218-228.
9. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 imporves blood pressure and glycaemic control: A controlled trial in subjects wit type 2 diabetes. Eur J Clinical Nutr 2002;56:1137-1142.
10. Bliznakov EG. Chopra RK, Bhagavan HN. Coenzyme Q10 and neoplasia: Overview of experimental and clinical evidence. In: Bagchi, D, Preuss HG, editors. Phytopharmaceuticals in cancer chemoprevention. Boca Raton: CRC Press; 2004. p 599-622.
11. Kishi H, Kishi T, Folkers K. Bioenergetics in clinical medicine. III. Inihibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs. Res Commun Chem Pathol Pharmacol 1975;12:533-540.


Qunol Ultra CoQ10 is distributed by QuTen Research Institute LLC located in Novato, CA, and is available at Target, Rite Aid, Longs, and Costco.com.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RmFsdS1NYWduLU1hZ24tU3VtbS1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Robin Bonnema
973-769-6470
Email us Here
Peter Boutros
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright